Cenote

Cenote is a YC W25 AI sales agent built for digital health brands to chase leads they have already paid for all the way to a closed deal. It binds HIPAA compliance to conversational selling, and is sold to telehealth and D2C prescription drug teams, with the tagline “like great care, not automation”.

Core capabilities

• Multi-channel outreach: inbound and outbound voice, SMS, WhatsApp and email run as a single chain, leaving no gap from answering questions to sending a payment link
• Three battle-tested playbooks: instant abandoned-checkout recovery, renewals and new-customer onboarding, and win-back of dormant users, all judged on conversion rather than hours worked
• Top-rep voice cloning: replicates the voice of the team's best closer so outbound calls sound like a consultant instead of a bot
• HIPAA context built into the product: the terms explicitly allow signing a BAA, and the privacy policy separately covers SMS opt-in, STOP/HELP, and the promise that opt-in data is not sold
• Mainstream tool integrations: six disclosed integration categories — HubSpot, Salesforce, Customer.io, Calendly, Stripe and Slack
• Live in seven days: the site says it runs without engineering support, and you can exit at any time

Use cases Best suited to US-market telehealth, GLP-1 weight loss, men's health and prescription skincare brands: steady ad spend, high abandonment and churn, and lead volume that has outgrown what human sales can carry. BetterMe Rx self-reports 3x abandoned-checkout recovery, and Brightmeds self-reports roughly USD 100k of revenue impact over two months plus about 800 hours of labor saved each month.

Unique advantages Peers mostly compete over answering calls, scheduling and reviews (Assort, Podium); Cenote does only outbound follow-up and churn win-back, and books the value against incremental conversion. It does not compete on deep EHR integration and does not disclose its underlying model vendor, so its moat sits in medical conversation data and managed implementation.

Editorial assessment The scenario is cut precisely, customers are real and onboarding is fast, which makes it a candidate worth putting on a shortlist for this narrow abandoned-checkout recovery gap. But the site has no public pricing, no Trust Center and no independent reviews, with only YC backing and self-reported customer numbers holding up the pitch. A fit for growth leads who already carry ad volume and can accept vendor-managed implementation; teams with fixed budgets or a wish to self-serve should look elsewhere first.